Stocks
Editas Medicine (EDIT) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -672.6% | -144.3% | -736.3% | -1 114% | -208.8% | -354.8% | ||
| Changes by years, y/y, % | -318pp | +528pp | -592pp | -378pp | +905pp | -10.1% | |||
Editas Medicine. EBITDA margin, %
Editas Medicine. EBITDA margin, changes, pp
Editas Medicine (EDIT) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | -911.7% | -37.5% | -5 778% | -13 739% | -99 249% | -354.8% | |
| Changes by years, y/y, % | +132 222pp | +933pp | -5 261pp | -12 212pp | -98 337pp | |||
| Changes by quarters, q/q, % | +616pp | +874pp | -5 741pp | -7 961pp | -85 510pp | |||
